Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07162818Phase 4Completed
Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy
Proliferative VitreoretinopathyRhegmatogenous Retinal Detachment
PrincipalinvestigatorStart date: 2021-04-28

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Ophthalmology, Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo Hospital, Indonesia

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael Altaweel, MD

University of Wisconsin, Madison

Moderately Similar
2 trials

Shared therapeutic areas:

Vitreoretinopathy, ProliferativeRhegmatogenous Retinal Detachment
Similarity Score30%

Leo Kim, MD, PhD

Massachusetts Eye and Ear

Moderately Similar
2 trials

Shared therapeutic areas:

Vitreoretinopathy, ProliferativeRhegmatogenous Retinal Detachment
Similarity Score30%

Ahmed M Abdelbaki, MD, PhD

Cairo University

Moderately Similar
1 trials

Shared therapeutic areas:

Vitreoretinopathy, ProliferativeRhegmatogenous Retinal Detachment
Similarity Score30%

Ahmed A Abdel-Kader, MD, PhD

Cairo University

Moderately Similar
3 trials

Shared therapeutic areas:

Vitreoretinopathy, ProliferativeRhegmatogenous Retinal Detachment
Similarity Score30%

Ahmed M Younes, MD, MSc

Cairo University

Moderately Similar
1 trials

Shared therapeutic areas:

Vitreoretinopathy, ProliferativeRhegmatogenous Retinal Detachment
Similarity Score30%

Hany S Hamza, MD, PhD

Cairo University

Moderately Similar
1 trials

Shared therapeutic areas:

Vitreoretinopathy, ProliferativeRhegmatogenous Retinal Detachment
Similarity Score30%

Ayman G Elnahry, MD, PhD

Cairo University

Moderately Similar
3 trials

Shared therapeutic areas:

Vitreoretinopathy, ProliferativeRhegmatogenous Retinal Detachment
Similarity Score30%

Hamid Ahmadieh, MD

Ophthalmic Research Center of Shaheed Beheshti Medical University

Moderately Similar
11 trials

Shared therapeutic areas:

Vitreoretinopathy, ProliferativeRhegmatogenous Retinal Detachment
Similarity Score30%

Ayman G. Elnahry, PhD

Cairo University

Related
1 trials

Shared therapeutic areas:

Rhegmatogenous Retinal Detachment
Similarity Score15%

Tamer F Elewa, MD

AinShams University

Related
1 trials

Shared therapeutic areas:

Rhegmatogenous Retinal Detachment
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07162818Phase 4PrincipalInvestigator

Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy

Proliferative VitreoretinopathyRhegmatogenous Retinal Detachment
Completed

All 1 trials loaded